220 related articles for article (PubMed ID: 6793632)
1. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
Fick RB; Naegel GP; Matthay RA; Reynolds HY
J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632
[TBL] [Abstract][Full Text] [Related]
2. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
[TBL] [Abstract][Full Text] [Related]
3. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
[TBL] [Abstract][Full Text] [Related]
5. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
Hornick DB; Fick RB
J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody?
Fick RB; Reynolds HY
Bull Eur Physiopathol Respir; 1983; 19(2):151-61. PubMed ID: 6871494
[TBL] [Abstract][Full Text] [Related]
7. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
[TBL] [Abstract][Full Text] [Related]
8. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
Bainbridge T; Fick RB
J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa.
Berger M; Norvell TM; Tosi MF; Emancipator SN; Konstan MW; Schreiber JR
Pediatr Res; 1994 Jan; 35(1):68-77. PubMed ID: 8134202
[TBL] [Abstract][Full Text] [Related]
10. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.
Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C
Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
Penketh AR; Pitt TL; Hodson ME; Batten JC
J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
Holby N; Olling S
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
[TBL] [Abstract][Full Text] [Related]
13. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
[TBL] [Abstract][Full Text] [Related]
16. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
McCormick LL; Karulin AY; Schreiber JR; Greenspan NS
J Immunol; 1997 Apr; 158(7):3474-82. PubMed ID: 9120309
[TBL] [Abstract][Full Text] [Related]
17. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.
Moss RB; Hsu YP; Sullivan MM; Lewiston NJ
Pediatr Res; 1986 May; 20(5):453-9. PubMed ID: 3714355
[TBL] [Abstract][Full Text] [Related]
18. Opsonic defect in patients with cystic fibrosis of the pancreas.
Biggar WD; Holmes B; Good RA
Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1716-9. PubMed ID: 5001942
[TBL] [Abstract][Full Text] [Related]
19. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
Marshall BC; Carroll KC
Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
